Kevin Marsh

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Sillah J, Sirugo G, Peshu N, Williams TN, Maitland K, Davies RJ, Kwiatkowski DP, Day NP, Yala D, Crook DW, Marsh K, Berkley JA, O'Neill LA, Hill AV
Nat Genet, (2007). 39:523-8

The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya.Atkinson SH, Mwangi TW, Uyoga SM, Ogada E, Macharia AW, Marsh K, Prentice AM, Williams TN
Clin Infect Dis, (2007). 44:802-9

Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue.Cordery DV, Kishore U, Kyes S, Shafi MJ, Watkins KR, Williams TN, Marsh K, Urban BC
J Infect Dis, (2007). 195:905-12

Sickle cell disease in Africa: burden and research priorities.Makani J, Williams TN, Marsh K
Ann Trop Med Parasitol, (2007). 101:3-14

Elevated plasma urokinase receptor predicts low birth weight in maternal malaria.Ostrowski SR, Shulman CE, Peshu N, Staalsoe T, Hoyer-Hansen G, Pedersen BK, Marsh K, Ullum H
Parasite Immunol, (2007). 29:37-46

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, Todryk S, Keating S, Lang T, Lowe B, Gikonyo C, Molyneux C, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV
PLoS Clin Trials, (2006). 1:e29

The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria.Urban BC, Cordery D, Shafi MJ, Bull PC, Newbold CI, Williams TN, Marsh K
Infect Immun, (2006). 74:6700-6

Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals.Bejon P, Keating S, Mwacharo J, Kai OK, Dunachie S, Walther M, Berthoud T, Lang T, Epstein J, Carucci D, Moris P, Cohen J, Gilbert SC, Peshu N, Marsh K, Hill AV
Infect Immun, (2006). 74:6331-8

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.Bejon P, Kai OK, Mwacharo J, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV
Eur J Immunol, (2006). 36:2264-72

Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients.Nery S, Deans AM, Mosobo M, Marsh K, Rowe JA, Conway DJ
Mol Biochem Parasitol, (2006). 149:208-15

Contrasting signatures of selection on the Plasmodium falciparum erythrocyte binding antigen gene family.Verra F, Chokejindachai W, Weedall GD, Polley SD, Mwangi TW, Marsh K, Conway DJ
Mol Biochem Parasitol, (2006). 149:182-90

Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.Persson KE, Lee CT, Marsh K, Beeson JG
J Clin Microbiol, (2006). 44:1665-73

CD4 T cells from malaria-nonexposed individuals respond to the CD36-Binding Domain of Plasmodium falciparum erythrocyte membrane protein-1 via an MHC class II-TCR-independent pathway.Ndungu FM, Sanni L, Urban B, Stephens R, Newbold CI, Marsh K, Langhorne J
J Immunol, (2006). 176:5504-12

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.Bejon P, Mwacharo J, Kai OK, Todryk S, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV
Vaccine, (2006). 24:4709-15

Frequencies of peripheral blood myeloid cells in healthy Kenyan children with alpha+ thalassemia and the sickle cell trait.Urban BC, Shafi MJ, Cordery DV, Macharia A, Lowe B, Marsh K, Williams TN
Am J Trop Med Hyg, (2006). 74:578-84

The effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya.Wambua S, Mwangi TW, Kortok M, Uyoga SM, Macharia AW, Mwacharo JK, Weatherall DJ, Snow RW, Marsh K, Williams TN
PLoS Med, (2006). 3:e158

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.Bejon P, Peshu N, Gilbert SC, Lowe BS, Molyneux CS, Forsdyke J, Lang T, Hill AV, Marsh K
Clin Infect Dis, (2006). 42:1102-10

High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi TW, Marsh K
Vaccine, (2006). 24:4233-46

Malaria in Africa: sources, risks, drivers & disease burden 2005-2030..Snow RW, Hay SI, Marsh K
Paper prepared for UK Government’s Foresight Project “Infectious Diseases: preparing for the future”., (2006). :

PREFACE..Marsh K
American Journal of Tropical Medicine & Hygiene , (2006). 75:i